Cited by 1,846Nanoparticle-Based Drug DeliveryBarrier Structure and Function StudiesDrug Transport and Resistance Mechanisms

Exploiting the enhanced permeability and retention effect for tumor targeting

Iyer, Arun K., Khaled, Greish, Fang, Jun, Maeda, Hiroshi·2006·Drug Discovery Today

Abstract

Of the tumor targeting strategies, the enhanced permeability and retention (EPR) effect of macromolecules is a key mechanism for solid tumor targeting, and considered a gold standard for novel drug design. In this review, we discuss various endogenous factors that can positively impact the EPR effect in tumor tissues. Further, we discuss ways to augment the EPR effect by use of exogenous agents, as well as practical methods available in the clinical setting. Some innovative examples developed by researchers to combat cancer by the EPR mechanism are also discussed.

Integrity signals

Registry

Crossref · 10.1016/j.drudis.2006.07.005

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Due to the enhanced permeability and retention effect, selective accumulation in solid tumors can be used to target hypoxic tumors more effectively.

    “Due to the enhanced permeability and retention effect (EPR effect), 174 selective accumulation in solid tumors can be used to target hypoxic tumors more effectively.”

The citation lists haven’t been fetched yet

References 85 · Cited by 1,846

Authors
Iyer, A. K., Khaled, G., Fang, J., & Maeda, H.
Affiliations
Sojo University (JP)
Corresponding author
Maeda, Hiroshi
Venue
Drug Discovery Today
Publisher
Elsevier BV
Published
2006-09
Volume
11
Issue
17-18
Pages
812-818
ISSN
1359-6446 (ISSN-L)
OpenAlex
W2027137358
Cited by
1,846
References
85
Citations by year
2026: 28 · 2025: 51 · 2024: 76 · 2023: 77 · 2022: 93 · 2021: 90 · 2020: 126 · 2019: 98 · 2018: 131 · 2017: 138 · 2016: 134 · 2015: 144 · 2014: 138 · 2013: 120 · 2012: 103
FWCI
2.71
Type
journal article
Language
en
Open access
closed
Locations
  • Drug Discovery Today (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
  • Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
Keywords
enhanced permeability and retention effect, tumor targeting, macromolecules, solid tumors, tumor microenvironment, internal factors, drug delivery, cancer therapeutics
MeSH terms
Animals, Antineoplastic Agents, Humans, Neoplasms, Permeability, Polymers, Drug Delivery Systems

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review